Global Celiac Drugs Report Thumbnail

Global Celiac Drugs Market by Type (First Line Of Treatment, Second Line Of Treatment), By Application (Men, Women, Children) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: PH-325
  • Author: Up Market Research
  • Rating: 4.5
  • Total Reviews: 73
  • No. Of Pages: 228
  • Format:
  • Pub. Date: 2021-03-01
  • Share:

The Global Celiac Drugs Market size is projected to grow at a CAGR of 5.8% during the forecast period 2018-2028. The growth in this market can be attributed to the increasing prevalence of celiac disease, raising awareness about celiac disease, and technological advancements in the field of celiac drugs. In this report, we have segmented the global celiac drugs market on the basis of type, application, and region.



Celiac drugs are medications that are used to treat celiac disease. Celiac disease is a condition in which the body cannot tolerate gluten, a protein found in wheat, barley, and rye. When people with celiac disease eat foods that contain gluten, they may experience abdominal pain, diarrhea, bloating, and fatigue. Celiac disease is a condition that causes damage to the lining of the small intestine and prevents it from absorbing parts of food that are important for staying healthy. People who have celiac disease cannot tolerate a protein called gluten, which is found in wheat, rye, and barley. When people with celiac disease eat foods or use products that contain gluten, their immune system responds by damaging the small intestine.



On the basis of Type, the global celiac drugs market is segmented into first line of treatment and second line of treatment.



First Line Of Treatment:

First line of treatment is the initial course of therapy that is recommended for a particular disease or condition. It is usually the most effective and least invasive form of treatment. First-line treatments are typically used before second-line treatments are considered. The first line of treatment for celiac disease is a gluten-free diet. This means avoiding all foods that contain wheat, rye, and barley. People with celiac disease must be careful to avoid even trace amounts of gluten in their diet. The gluten-free diet is the only currently available treatment for celiac disease. It is a lifelong diet that requires careful planning and labels reading to avoid hidden sources of gluten.



Second Line Of Treatment:

Second line of treatment is a type of celiac drug that is used when the first line of treatment fails. Second-line treatments are typically more aggressive and have more side effects than first-line treatments. Some common second-line treatments for celiac disease include immunosuppressants, anti-inflammatory drugs, and biological therapies. Second line of treatment for celiac disease is generally a gluten-free diet. This means eliminating all foods that contain gluten from the diet. This can be a challenge, as gluten is found in many common foods, such as bread, pasta, cereal, and baked goods.



On the basis of Application, the global celiac drugs market is segmented into men, women, and children.



On the basis of Region, the global celiac drugs market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The celiac drugs market in North America is expected to grow at a significant rate during the forecast period. This growth can be attributed to the rising prevalence of celiac disease and the availability of advanced treatments in this region. Moreover, increasing awareness about the disease and its treatment options is also fueling the market growth in North America. The European region is expected to be the second-largest market for celiac drugs due to the high prevalence of celiac disease in this region. The prevalence of the celiac disease is estimated to be about one in every 100 people in Europe. Moreover, the availability of new and innovative treatments and the increasing awareness about celiac disease are also expected to drive market growth in this region.

The Asia Pacific region is expected to be the fastest-growing market for celiac drugs due to the increasing prevalence of celiac disease in this region. The high growth of this region is attributed to the growing awareness about celiac disease and the rise in disposable incomes. China and India are expected to be the major contributors to the market growth in this region. The Middle East & Africa region is expected to witness moderate growth during the forecast period due to the low prevalence of celiac disease in this region. However, the availability of new and innovative treatments and the increasing awareness about celiac disease are expected to drive market growth in this region.



Growth Factors For The Global Celiac Drugs Market:

The global celiac drugs market is growing due to the increase in the number of people suffering from celiac disease. The number of people diagnosed with celiac disease has been increasing over the years, owing to the awareness about the condition and the availability of better diagnostic tools. This has resulted in an increased demand for celiac drugs globally. Moreover, the development of new and improved treatments for celiac disease is another factor that is expected to drive the growth of the global celiac drugs market during the forecast period.



Up Market Research published a new report titled “Celiac Drugs Market research report which is segmented by Types (First Line Of Treatment, Second Line Of Treatment), By Applications (Men, Women, Children), By Players/Companies ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer, Biogen, BioLineRx, Biotest, Bristol-Myers Squibb, Celgene, Celimmune, F Hoffmann-La Roche, ImmunogenX, Immunomedics, ImmusanT, Innovate Biopharmaceuticals, Johnson & Johnson, Kedrion Biopharma, LFB Group, Merck, Novartis”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

 

Report Scope

Report Attributes Report Details
Report Title Celiac Drugs Market Research Report
By Type First Line Of Treatment, Second Line Of Treatment
By Application Men, Women, Children
By Companies ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer, Biogen, BioLineRx, Biotest, Bristol-Myers Squibb, Celgene, Celimmune, F Hoffmann-La Roche, ImmunogenX, Immunomedics, ImmusanT, Innovate Biopharmaceuticals, Johnson & Johnson, Kedrion Biopharma, LFB Group, Merck, Novartis
Regions Covered North America, Europe, APAC, Latin America, MEA
Base Year 2020
Historical Year 2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year 2028
Number of Pages 228
Number of Tables & Figures 160
Customization Available Yes, the report can be customized as per your need.
 

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Celiac Drugs Industry Outlook
 

Global Celiac Drugs Market Report Segments:

The market is segmented by Type First Line Of Treatment, Second Line Of Treatment and By Application Men, Women, Children.

 

Some of the companies that are profiled in this report are:

  1. ADMA Biologics
  2. Amgen
  3. Anthera Pharmaceuticals
  4. Bayer
  5. Biogen
  6. BioLineRx
  7. Biotest
  8. Bristol-Myers Squibb
  9. Celgene
  10. Celimmune
  11. F Hoffmann-La Roche
  12. ImmunogenX
  13. Immunomedics
  14. ImmusanT
  15. Innovate Biopharmaceuticals
  16. Johnson & Johnson
  17. Kedrion Biopharma
  18. LFB Group
  19. Merck
  20. Novartis
 

Celiac Drugs Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

 

Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Celiac Drugs Market
 

Overview of the regional outlook of the Celiac Drugs Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Celiac Drugs Market Overview
 

Highlights of The Celiac Drugs Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Celiac Drugs Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. First Line Of Treatment

                2. Second Line Of Treatment

       7. By Application:

                1. Men

                2. Women

                3. Children

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.
 

We have studied the Celiac Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

 

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Celiac Drugs Market Statistics
 

Reasons to Purchase the Celiac Drugs Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Celiac Drugs Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Celiac Drugs Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Celiac Drugs Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Celiac Drugs Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Celiac Drugs Market Size & Forecast, 2018-2028 
      4.5.1 Celiac Drugs Market Size and Y-o-Y Growth 
      4.5.2 Celiac Drugs Market Absolute $ Opportunity 


Chapter 5 Global Celiac Drugs Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Celiac Drugs Market Size Forecast by Type
      5.2.1 First Line Of Treatment
      5.2.2 Second Line Of Treatment
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Celiac Drugs Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Celiac Drugs Market Size Forecast by Applications
      6.2.1 Men
      6.2.2 Women
      6.2.3 Children
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Celiac Drugs Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Celiac Drugs Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Celiac Drugs Analysis and Forecast
   9.1 Introduction
   9.2 North America Celiac Drugs Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Celiac Drugs Market Size Forecast by Type
      9.6.1 First Line Of Treatment
      9.6.2 Second Line Of Treatment
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Celiac Drugs Market Size Forecast by Applications
      9.10.1 Men
      9.10.2 Women
      9.10.3 Children
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Celiac Drugs Analysis and Forecast
   10.1 Introduction
   10.2 Europe Celiac Drugs Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Celiac Drugs Market Size Forecast by Type
      10.6.1 First Line Of Treatment
      10.6.2 Second Line Of Treatment
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Celiac Drugs Market Size Forecast by Applications
      10.10.1 Men
      10.10.2 Women
      10.10.3 Children
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Celiac Drugs Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Celiac Drugs Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Celiac Drugs Market Size Forecast by Type
      11.6.1 First Line Of Treatment
      11.6.2 Second Line Of Treatment
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Celiac Drugs Market Size Forecast by Applications
      11.10.1 Men
      11.10.2 Women
      11.10.3 Children
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Celiac Drugs Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Celiac Drugs Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Celiac Drugs Market Size Forecast by Type
      12.6.1 First Line Of Treatment
      12.6.2 Second Line Of Treatment
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Celiac Drugs Market Size Forecast by Applications
      12.10.1 Men
      12.10.2 Women
      12.10.3 Children
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Celiac Drugs Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Celiac Drugs Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Celiac Drugs Market Size Forecast by Type
      13.6.1 First Line Of Treatment
      13.6.2 Second Line Of Treatment
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Celiac Drugs Market Size Forecast by Applications
      13.10.1 Men
      13.10.2 Women
      13.10.3 Children
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Celiac Drugs Market: Competitive Dashboard
   14.2 Global Celiac Drugs Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 ADMA Biologics
      14.3.2 Amgen
      14.3.3 Anthera Pharmaceuticals
      14.3.4 Bayer
      14.3.5 Biogen
      14.3.6 BioLineRx
      14.3.7 Biotest
      14.3.8 Bristol-Myers Squibb
      14.3.9 Celgene
      14.3.10 Celimmune
      14.3.11 F Hoffmann-La Roche
      14.3.12 ImmunogenX
      14.3.13 Immunomedics
      14.3.14 ImmusanT
      14.3.15 Innovate Biopharmaceuticals
      14.3.16 Johnson & Johnson
      14.3.17 Kedrion Biopharma
      14.3.18 LFB Group
      14.3.19 Merck
      14.3.20 Novartis
Segments Covered in the Report
The global Celiac Drugs market has been segmented based on

By Types
  • First Line Of Treatment
  • Second Line Of Treatment
By Applications
  • Men
  • Women
  • Children
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • ADMA Biologics
  • Amgen
  • Anthera Pharmaceuticals
  • Bayer
  • Biogen
  • BioLineRx
  • Biotest
  • Bristol-Myers Squibb
  • Celgene
  • Celimmune
  • F Hoffmann-La Roche
  • ImmunogenX
  • Immunomedics
  • ImmusanT
  • Innovate Biopharmaceuticals
  • Johnson & Johnson
  • Kedrion Biopharma
  • LFB Group
  • Merck
  • Novartis

Buy Report